PRENOSIS, INC

Prenosis, Inc. specializes in the design and validation of predictive analytics systems for clinical decision support, with a focus on infectious disease severity prediction and immune response profiling. The company develops point-of-care diagnostic tools grounded in computational biology and machine learning, translating complex immunological data into actionable clinical insights. Their work centers on validating biomarker panels and algorithmic models for real-time use in hospital settings, particularly in sepsis risk stratification and infection outcome forecasting. Technical expertise includes clinical data integration from EHRs, statistical modeling of high-dimensional immune parameters, and regulatory-compliant validation of diagnostic algorithms under GCP and CLIA-aligned frameworks. Prenosis distinguishes itself through its ability to bridge translational research with frontline clinical workflows, ensuring analytical tools are both scientifically rigorous and operationally feasible in acute care environments. The company has delivered research and development services to the Department of Health and Human Services and the Department of Defense, focusing on clinical validation of diagnostic platforms for infectious disease management. For HHS, this has involved multi-site clinical studies evaluating the feasibility and diagnostic accuracy of immunoscore-based tools; for DoD, the work has centered on predictive analytics systems to anticipate disease progression in combat and field medical settings, aligning with military healthcare readiness priorities. Prenosis operates primarily under NAICS 541715, which encompasses applied research in life sciences with an emphasis on diagnostic innovation. Their market positioning is niche but critical—specializing in the translation of immunological research into deployable point-of-care technologies for infection management, a high-need area in both civilian and defense healthcare systems. As a small business structured as a 2L entity based in Chicago, Illinois, Prenosis maintains a focused, agile development model. While currently without federal certifications, its technical work is conducted under strict clinical and research compliance standards, positioning it as a specialized provider for evidence-based diagnostic innovation within federal health and defense research portfolios.